ArcticZymes Technologies ASA (STU:B4V)
€ 1.114 -0.002 (-0.18%) Market Cap: 56.93 Mil Enterprise Value: 37.30 Mil PE Ratio: 167.50 PB Ratio: 2.15 GF Score: 62/100

Q1 2024 Arcticzymes Technologies ASA Earnings Call Transcript

May 08, 2024 / 06:30AM GMT
Release Date Price: €1.95 (-7.61%)
Michael Akoh
Arcticzymes Technologies ASA - Chief Executive Officer

It's a rather early start for me. So I apologize if I sound a bit more tired and look a bit more tired than usual, but I'm sure we're going to get through this presentation in good style. I'm in the US because I'm attending a very important Congress. I am here together with our commercial team. It's the American Society of Gene and Cell Therapy that is going to kick off today, yesterday was the opening reception, and it's great to see that the industry is still driving spend some difficult years.

But the first talks I had with the partners and clients yesterday showed that there's a cautious optimism in a sector that has been hit rather hard during the last the year. We have a presentation for you today and Børge, if I can ask you to switch to the next slide. Thank you. A quick look at the agenda. I'm going to start off by giving you an overview of the company. We have a lot of new people joining us each time we do these presentations. So just a quick run-through of ArcticZymes and the journey we are on.

Now I'm going

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot